Evotec SE (EVO) stock
EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.48−0.08 (-5.13%)
Close on Nov 17, 2026Market cap $526.23MP/E –Yield –
Evotec profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2022 it was -23.4%, against 34.9% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -23.4% | −58.2 |
| FY2021 | Dec 31, 2021 | 34.9% | +33.6 |
| FY2020 | Dec 31, 2020 | 1.3% | −7.3 |
| FY2019 | Dec 31, 2019 | 8.5% | – |
See a number that looks wrong?